Literature DB >> 19037517

A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals.

Thean Yen Tan1, Ai Ling Tan, Nancy W S Tee, Lily S Y Ng.   

Abstract

INTRODUCTION: Worldwide, Candida albicans is the most common Candida species implicated in bloodstream infections. However, the proportion of non-albicans bloodstream infections is increasing. Fluconazole resistance is known to be more common in non-albicans species, but is also reported in C. albicans. This retrospective study was performed to determine the species epidemiology of Candida bloodstream infections in Singapore hospitals, and to perform susceptibility testing to a range of antifungal drugs.
MATERIALS AND METHODS: Candida spp. isolated from bloodstream infections from October 2004 to December 2006 were collected from 3 participating hospitals: a tertiary referral hospital (Singapore General Hospital), a secondary referral hospital (Changi General Hospital) and an obstetrics/paediatric hospital [KK Women's and Children's Hospital (KKWCH)]. Isolate collection was also retrospectively extended to January 2000 for KKWCH because of the limited number of cases from this hospital. Isolates were identified by a common protocol, and antifungal susceptibility testing was performed by microbroth dilution (Sensititre One, Trek Diagnostics, United Kingdom).
RESULTS: The most common isolates were C. albicans (37%), C. tropicalis (27%) and C. glabrata (16%). There were differences in species distribution between institutions, with C. parapsilosis and C. albicans predominant in KKWCH, and C. albicans and C. tropicalis predominant in the other 2 institutions. Fluconazole resistance was detected in 3.2% of all Candida spp., and 85.3% were classified as susceptible. All C. albicans and C. parapsilosis were susceptible to fluconazole and voriconazole, while susceptibility to fluconazole was much more variable for C. glabrata and C. krusei.
CONCLUSION: This study shows that C. albicans remains the predominant Candida species isolated from bloodstream infections in the 3 participating hospitals. However, non-albicans species accounted for nearly two-thirds of all cases of candidaemia. Resistance to fluconazole was uncommon, and was generally confined to C. krusei and C. glabrata.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19037517

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  17 in total

Review 1.  Candida peritonitis: an update on the latest research and treatments.

Authors:  Herman Anthony Carneiro; Anastasios Mavrakis; Eleftherios Mylonakis
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

Review 2.  Persistent spontaneous fungal peritonitis secondary to Candida albicans in a patient with alcoholic cirrhosis and review of the literature.

Authors:  Aneela Majeed; Waqas Ullah; Umar Zahid; Mayar Al Mohajer
Journal:  BMJ Case Rep       Date:  2016-11-08

3.  Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).

Authors:  Michael A Pfaller; Shawn A Messer; Ronald N Jones; Mariana Castanheira
Journal:  J Antibiot (Tokyo)       Date:  2015-04-22       Impact factor: 2.649

4.  Ibuprofen-mediated reversal of fluconazole resistance in clinical isolates of Candida.

Authors:  Monika Sharma; Debasis Biswas; Aarti Kotwal; Bhaskar Thakuria; Barnali Kakati; Bhupendra Singh Chauhan; Abhishek Patras
Journal:  J Clin Diagn Res       Date:  2015-01-01

5.  Antibiotic overuse as a risk factor for candidemia in an Indian pediatric ICU.

Authors:  Charu Agrawal; Debasis Biswas; Alpa Gupta; Bhupendra Singh Chauhan
Journal:  Indian J Pediatr       Date:  2014-11-29       Impact factor: 1.967

6.  Evaluation of Candida species and antifungal susceptibilities among children with invasive candidiasis.

Authors:  Murat Sütçü; Manolya Acar; Gonca Erköse Genç; İlknur Kökçü; Hacer Aktürk; Gürkan Atay; Selda Hançerli Törun; Nuran Salman; Zayre Erturan; Ayper Somer
Journal:  Turk Pediatri Ars       Date:  2017-09-01

7.  Fluconazole-, amphotericin-B-, caspofungin-, and anidulafungin-resistant Candida ciferrii: an unknown cause of systemic mycosis in a child.

Authors:  Hasan Agın; Yüce Ayhan; Ilker Devrim; Gamze Gülfidan; Sener Tulumoglu; Ertan Kayserili
Journal:  Mycopathologia       Date:  2011-04-03       Impact factor: 2.574

8.  Spectrum and prevalence of fungi infecting deep tissues of lower-limb wounds in patients with type 2 diabetes.

Authors:  Gopi Chellan; Shashikala Shivaprakash; Sundaram Karimassery Ramaiyar; Ajit Kumar Varma; Narendra Varma; Mangalanandan Thekkeparambil Sukumaran; Jayakumar Rohinivilasam Vasukutty; Arun Bal; Harish Kumar
Journal:  J Clin Microbiol       Date:  2010-04-21       Impact factor: 5.948

9.  Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.

Authors:  M A Pfaller; S A Messer; R J Hollis; L Boyken; S Tendolkar; J Kroeger; D J Diekema
Journal:  J Clin Microbiol       Date:  2009-08-05       Impact factor: 5.948

Review 10.  Yeasts in the gut: from commensals to infectious agents.

Authors:  Jürgen Schulze; Ulrich Sonnenborn
Journal:  Dtsch Arztebl Int       Date:  2009-12-18       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.